Clinical Trial Details
| Trial ID: | L3700 |
| Source ID: | NCT00734669 |
| Associated Drug: | Glibenclamide |
| Title: | Risk of Hypoglycemia in Type 2 Diabetes |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes |
| Interventions: | DRUG: Glibenclamide |
| Outcome Measures: | Primary: Number of hypoglycemic events, 3 days | Secondary: Secretion of hormones increasing blood glucose, effect of exercise on hypoglycemic events, postprandial glucose excursions, heart rate and forearm blood flow at hypoglycemia, 3 days |
| Sponsor/Collaborators: | Sponsor: University of Giessen | Collaborators: Merck Sharp & Dohme LLC |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | |
| Enrollment: | 12 |
| Study Type: | OBSERVATIONAL |
| Study Designs: | Observational Model: |Time Perspective: p |
| Start Date: | 2008-07 |
| Completion Date: | 2016-10 |
| Results First Posted: | |
| Last Update Posted: | 2016-10-26 |
| Locations: | |
| URL: | https://clinicaltrials.gov/show/NCT00734669 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|